| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-31150SS | |||
| Azide and BSA Free | NBP2-80983 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-80701-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-86010-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-91993-25ul | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 488 | DDX0481A488-100 | |||
| Alexa Fluor 546 | DDX0481A546-100 | |||
| Alexa Fluor 647 | DDX0481A647-100 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB500-266SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71006 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61872-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-37713 | |||
![Western Blot: TLR9 Antibody (2A4C6.2E5) [NBP2-31150] - Mouse Liver (lane 1), Mouse Kidney (lane 2) and Mouse Spleen (lane 3) were separated by SDS-PAGE and the protein transferred to PVDF. The membrane was then probed with anti-TLR9 at 2ug/mL and detected with an anti-rat HRP secondary antibody using chemiluminescence.](http://images.novusbio.com/fullsize/TLR9-Antibody-2E5-Western-Blot-NBP2-31150-img0007.jpg "Western Blot: TLR9 Antibody (2A4C6.2E5) [NBP2-31150] - Mouse Liver (lane 1), Mouse Kidney (lane 2) and Mouse Spleen (lane 3) were separated by SDS-PAGE and the protein transferred to PVDF. The membrane was then probed with anti-TLR9 at 2ug/mL and detected with an anti-rat HRP secondary antibody using chemiluminescence.")
![Immunohistochemistry-Paraffin: TLR9 Antibody (2A4C6.2E5) [NBP2-31150] - Analysis of TLR9 protein in normal mouse epididymis section using TLR9 antibody (clone 2E5) at a concentration of 5 ug/mL. This antibody developed strong cytoplasmic staining in the pseudostratified columnar epithelial cells as well as the blood vessels of epididymis. The basal cells, the smooth muscle cells and the mature sperm cells were largely found negative for TLR9 staining.](http://images.novusbio.com/fullsize/TLR9-Antibody-2E5-Immunohistochemistry-Paraffin-NBP2-31150-img0006.jpg)
![Western Blot: TLR9 Antibody (2A4C6.2E5) [NBP2-31150] - TLR9 Antibody (2E5) [NBP2-31150] - TLR9 Antibody (2E5) [NBP2-31150] - WB analysis of partial recombinant TLR9 protein (expected molecular weight ~21kDa) with TLR9 antibody (clone 2A4C6.2E5) at a concentration of 2 ug/mL.](http://images.novusbio.com/fullsize/TLR9-Antibody-2E5-Western-Blot-NBP2-31150-img0004.jpg)
![Immunohistochemistry-Paraffin: CD81 Antibody [NBP1-80701] - Analysis in human testis and skeletal muscle tissues. Corresponding RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD81-Antibody-Immunohistochemistry-Paraffin-NBP1-80701-img0006.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD81 Antibody [NBP1-80701] - Analysis in human testis and skeletal muscle tissues. Corresponding RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: CD81 Antibody [NBP1-80701] - Staining of human cell line U-2 OS shows localization to plasma membrane & cytosol. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/CD81-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-80701-img0004.jpg)
![Immunohistochemistry-Paraffin: CD81 Antibody [NBP1-80701] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/CD81-Antibody-Immunohistochemistry-Paraffin-NBP1-80701-img0010.jpg)
![Immunohistochemistry-Paraffin: CD81 Antibody [NBP1-80701] - Staining of human testis shows strong membranous positivity in cells in seminiferous ducts.](http://images.novusbio.com/fullsize/CD81-Antibody-Immunohistochemistry-Paraffin-NBP1-80701-img0007.jpg)
![Immunohistochemistry-Paraffin: CD81 Antibody [NBP1-80701] - Staining of human prostate shows moderate membranous positivity in glandular cells.](http://images.novusbio.com/fullsize/CD81-Antibody-Immunohistochemistry-Paraffin-NBP1-80701-img0008.jpg)
![Immunohistochemistry-Paraffin: CD81 Antibody [NBP1-80701] - Staining of human prostate shows weak to moderate membranous positivity in smooth muscle cells.](http://images.novusbio.com/fullsize/CD81-Antibody-Immunohistochemistry-Paraffin-NBP1-80701-img0009.jpg)
![Immunocytochemistry/Immunofluorescence: CD38 Antibody [NBP1-86010] - Staining of human cell line A549 shows localization to plasma membrane. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/CD38-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-86010-img0009.jpg "Immunocytochemistry/Immunofluorescence: CD38 Antibody [NBP1-86010] - Staining of human cell line A549 shows localization to plasma membrane. Antibody staining is shown in green.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD38 Antibody [NBP1-86010] - Staining in human tonsil and kidney tissues using NBP1-86010 antibody. Corresponding CD38 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD38-Antibody-Immunohistochemistry-Paraffin-NBP1-86010-img0021.jpg)
![Immunohistochemistry-Paraffin: CD38 Antibody [NBP1-86010] - Staining of human kidney shows no positivity in cells in tubules as expected.](http://images.novusbio.com/fullsize/CD38-Antibody-Immunohistochemistry-Paraffin-NBP1-86010-img0017.jpg)
![Immunohistochemistry-Paraffin: CD38 Antibody [NBP1-86010] - Staining of human prostate shows strong membranous/cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/CD38-Antibody-Immunohistochemistry-Paraffin-NBP1-86010-img0018.jpg)
![Immunohistochemistry-Paraffin: CD38 Antibody [NBP1-86010] - Staining of human rectum shows strong membranous/cytoplasmic positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD38-Antibody-Immunohistochemistry-Paraffin-NBP1-86010-img0019.jpg)
![Immunohistochemistry-Paraffin: CD38 Antibody [NBP1-86010] - Staining of human tonsil shows strong membranous/cytoplasmic positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/CD38-Antibody-Immunohistochemistry-Paraffin-NBP1-86010-img0020.jpg)
![Immunohistochemistry-Paraffin: HLA DOA Antibody [NBP1-91993] - Analysis in human tonsil and liver tissues using NBP1-91993 antibody. Corresponding HLA-DOA RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/HLA-DOA-Antibody-Immunohistochemistry-Paraffin-NBP1-91993-img0010.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: HLA DOA Antibody [NBP1-91993] - Analysis in human tonsil and liver tissues using NBP1-91993 antibody. Corresponding HLA-DOA RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: HLA DOA Antibody [NBP1-91993] - Staining of human liver shows no positivity in hepatocytes as expected.](http://images.novusbio.com/fullsize/HLA-DOA-Antibody-Immunohistochemistry-Paraffin-NBP1-91993-img0014.jpg)
![Immunohistochemistry-Paraffin: HLA DOA Antibody [NBP1-91993] - Staining of human tonsil shows strong granular cytoplasmic positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/HLA-DOA-Antibody-Immunohistochemistry-Paraffin-NBP1-91993-img0011.jpg)
![Immunohistochemistry-Paraffin: HLA DOA Antibody [NBP1-91993] - Staining of human pancreas shows no positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/HLA-DOA-Antibody-Immunohistochemistry-Paraffin-NBP1-91993-img0013.jpg)
![Western Blot: CD4 Antibody (BLR167J) [NBP3-14741] - Whole cell lysate (10 ug) from NIH 3T3, BW5147.3, mouseThymus, 70Z/3, and EL4 cells prepared using NETN lysisbuffer. Antibody: Rabbit anti-CD4 recombinant monoclonalantibody [BLR167J] used at 1:1000.Secondary: HRP-conjugated goat anti-rabbit IgGChemiluminescence with an exposure timeof 30 seconds. Lower Panel: Rabbit anti-Actin recombinantmonoclonal antibody [BLR057F].](http://images.novusbio.com/fullsize/CD4-Antibody-BLR167J-Western-Blot-NBP3-14741-img0003.jpg)
![Immunohistochemistry-Paraffin: CD4 Antibody (BLR167J) [NBP3-14741] - Mouse lung, : Rabbit anti-CD4 recombinant monoclonal antibody [BLR167J]. Secondary: HRP-conjugated goat anti-rabbit IgG Substrate: DAB.](http://images.novusbio.com/fullsize/CD4-Antibody-BLR167J-Immunohistochemistry-Paraffin-NBP3-14741-img0006.jpg)
![Immunohistochemistry-Paraffin: CD4 Antibody (BLR167J) [NBP3-14741] - Mouse spleen, Rabbit anti-CD4 recombinant monoclonal antibody [BLR167J]. Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/CD4-Antibody-BLR167J-Immunohistochemistry-Paraffin-NBP3-14741-img0004.jpg)
![Immunohistochemistry-Paraffin: CD4 Antibody (BLR167J) [NBP3-14741] - Mouse gut, Rabbit anti-CD4 recombinant monoclonal antibody [BLR167J]. Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/CD4-Antibody-BLR167J-Immunohistochemistry-Paraffin-NBP3-14741-img0005.jpg)
![Immunoprecipitation: CD4 Antibody [NBP3-14741] - s: Whole cell lysate (200 ugper IP reaction; 10% of IP loaded) from mouse thymus.Antibodies: Rabbit anti-CD4 recombinant monoclonalantibody used for IP at 6 ul/200ug lysate. CD4 was also immunoprecipitated by anotherantibody against a different epitope of CD4 For blotting immunoprecipitated CD4, was used at 1:1000. Chemiluminescence withan exposure time of 30 seconds.](http://images.novusbio.com/fullsize/CD4-Antibody-Immunoprecipitation-NBP3-14741-img0001.jpg)
![Flow Cytometry: CD46 Antibody (MEM-258) [NB500-301] - Staining of human peripheral blood cells with anti-CD46 (MEM-258) Alexa Fluor® 700.](http://images.novusbio.com/fullsize/CD46-Antibody-MEM-258-Flow-Cytometry-NB500-301-img0006.jpg "Flow Cytometry: CD46 Antibody (MEM-258) [NB500-301] - Staining of human peripheral blood cells with anti-CD46 (MEM-258) Alexa Fluor® 700.")
![Flow Cytometry: CD46 Antibody (MEM-258) [NB500-301] - Surface staining of human peripheral blood cells with anti-CD46 (MEM-258) PE](http://images.novusbio.com/fullsize/CD46-Antibody-MEM-258-Flow-Cytometry-NB500-301-img0001.jpg)
![Flow Cytometry: CD46 Antibody (MEM-258) [NB500-301] - Surface staining of human peripheral blood cells with anti-CD46 (MEM-258) biotin](http://images.novusbio.com/fullsize/CD46-Antibody-MEM-258-Flow-Cytometry-NB500-301-img0002.jpg)
![Flow Cytometry: CD46 Antibody (MEM-258) [NB500-301] - Staining of human peripheral blood cells with anti-CD46 (MEM-258) Pacific BlueTM.](http://images.novusbio.com/fullsize/CD46-Antibody-MEM-258-Flow-Cytometry-NB500-301-img0003.jpg)
![Flow Cytometry: CD46 Antibody (MEM-258) [NB500-301] - Staining of human peripheral blood cells with anti-CD46 (MEM-258) APC.](http://images.novusbio.com/fullsize/CD46-Antibody-MEM-258-Flow-Cytometry-NB500-301-img0004.jpg)
![Flow Cytometry: CD46 Antibody (MEM-258) [NB500-301] - Staining of human peripheral blood cells with anti-CD46 (MEM-258) FITC.](http://images.novusbio.com/fullsize/CD46-Antibody-MEM-258-Flow-Cytometry-NB500-301-img0005.jpg)
![Functional (Inhibition): TIRAP (TLR2 and TLR4) Inhibitor Peptide Set [NBP2-29331] - TLR2/NF-kB/SEAPorter HEK 293 (NBP2-26274) cells were plated in 96-well plates at 5 x 10^4 cells/well for 16 h. Cells were preincubated with different concentrations (0, 1, 5, 10, 25 and 50 uM) of Inhibitory Peptide (NBP2-29331) and Control Peptide (NBP2-29334) for 1 h. Cells were then stimulated with 1 ng/ml Pam3CSK4 (NBP2-25297) for 24 h. Secreted alkaline phosphatase (SEAP) was analyzed using SEAPorter Assay Kit (NBP2-25285). *p < 0.05 versus control peptide at the corresponding concentrations (Mann-Whitney U test).](http://images.novusbio.com/fullsize/TIRAP-TLR2-and-TLR4-Inhibitor-Peptide-Set-Functional-Inhibition-NBP2-29331-img0001.jpg "Functional (Inhibition): TIRAP (TLR2 and TLR4) Inhibitor Peptide Set [NBP2-29331] - TLR2/NF-kB/SEAPorter HEK 293 (NBP2-26274) cells were plated in 96-well plates at 5 x 10^4 cells/well for 16 h. Cells were preincubated with different concentrations (0, 1, 5, 10, 25 and 50 uM) of Inhibitory Peptide (NBP2-29331) and Control Peptide (NBP2-29334) for 1 h. Cells were then stimulated with 1 ng/ml Pam3CSK4 (NBP2-25297) for 24 h. Secreted alkaline phosphatase (SEAP) was analyzed using SEAPorter Assay Kit (NBP2-25285). *p < 0.05 versus control peptide at the corresponding concentrations (Mann-Whitney U test).")
![Immunocytochemistry/Immunofluorescence: TLR8 Antibody (307D3.01) [DDX0481P-100] - Murine peyer patch - TLR8](http://images.novusbio.com/fullsize/TLR8-Antibody-307D3-01-Immunocytochemistry-Immunofluorescence-DDX0481P-100-img0002.jpg "Immunocytochemistry/Immunofluorescence: TLR8 Antibody (307D3.01) [DDX0481P-100] - Murine peyer patch - TLR8")
![Immunohistochemistry-Frozen: TLR8 Antibody (307D3.01) [DDX0481P-100] - Analysis using the Alexa Fluor (R) 488 conjugate of DDX0481P-100. Staining of human tonsil frozen section.](http://images.novusbio.com/fullsize/TLR8-Antibody-307D3-01-Immunohistochemistry-Frozen-DDX0481P-100-img0003.jpg)
![Flow Cytometry: TLR8 Antibody (307D3.01) [DDX0481P-100] - Facs staining of TLR8-transfected293T cells with 307D3](http://images.novusbio.com/fullsize/TLR8-Antibody-307D3-01-Flow-Cytometry-DDX0481P-100-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: TLR8 Antibody (307D3.01) [DDX0481P-100] - Murine peyer patch - TLR8](http://images.novusbio.com/fullsize/TLR8-Antibody-307D3-01-Immunocytochemistry-Immunofluorescence-DDX0481P-100-img0001.jpg)
![Western Blot: Beclin 1 Antibody [NB500-266] - Detection of Beclin 1 in liver lysates using NB500-266. (1) mouse liver and (2) human liver.](http://images.novusbio.com/fullsize/Beclin-1-Antibody-Western-Blot-NB500-266-img0002.jpg "Western Blot: Beclin 1 Antibody [NB500-266] - Detection of Beclin 1 in liver lysates using NB500-266. (1) mouse liver and (2) human liver.")
![Western Blot: IFIT3 Antibody (OTI1G1) [NBP2-02148] - Analysis of extracts (35ug) from 9 different cell lines by using anti-IFIT3 monoclonal antibody at 1:200 dilution. (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human)](http://images.novusbio.com/fullsize/IFIT3-Antibody-OTI1G1-Western-Blot-NBP2-02148-img0010.jpg "Western Blot: IFIT3 Antibody (OTI1G1) [NBP2-02148] - Analysis of extracts (35ug) from 9 different cell lines by using anti-IFIT3 monoclonal antibody at 1:200 dilution. (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human)")
![Immunocytochemistry/Immunofluorescence: IFIT3 Antibody (OTI1G1) [NBP2-02148] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY IFIT3.](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Immunocytochemistry-Immunofluorescence-NBP2-02148-img0009.jpg)
![Flow Cytometry: IFIT3 Antibody (1G1) [NBP2-02148] - Analysis of Jurkat cells, using anti-IFIT3 antibody, (Red) compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Flow-Cytometry-NBP2-02148-img0001.jpg)
![Western Blot: IFIT3 Antibody (1G1) [NBP2-02148] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IFIT3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IFIT3.](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Western-Blot-NBP2-02148-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: IFIT3 Antibody (1G1) [NBP2-02148] - Immunofluorescent staining of HT29 cells using anti-IFIT3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Immunocytochemistry-Immunofluorescence-NBP2-02148-img0003.jpg)
![IFIT3 Antibody (OTI1G1)[NBP2-02148]Simple Western� analysis of endogenous protein GBE1 from SH-SY5Y lysates (0.1mg/mL) using GBE1 Mouse Monoclonal Antibody . The virtual lane view (left) shows the target (as indicated) at a 1:50 dilution of primary antibody. The corresponding electropherogram view (right) plots chemiluminescence by molecular weight along the capillary at a 1:50 dilution of primary antibody. This experiment was performed under reducing conditions on the Jess� Simple Western instrument from ProteinSimple, a Bio-Techne brand, using the 12�230 kDa Separation Module.](http://images.novusbio.com/fullsize/nbp2-02148_mouse-ifit3-mab-oti1g1-simple-western-131120251236354.jpg%253fstore=america&image-type=image)
![Western Blot: HLA B Antibody (2A11G7) [NBP2-61872] - Analysis using HLA-B mAb against HEK293 (1) and HLA-B (AA: 241-362)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/HLA-B-Antibody-2A11G7-Western-Blot-NBP2-61872-img0006.jpg "Western Blot: HLA B Antibody (2A11G7) [NBP2-61872] - Analysis using HLA-B mAb against HEK293 (1) and HLA-B (AA: 241-362)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunohistochemistry-Paraffin: HLA B Antibody (2A11G7) [NBP2-61872] - Analysis of bladder cancer tissues using HLA-B mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/HLA-B-Antibody-2A11G7-Immunohistochemistry-NBP2-61872-img0004.jpg)
![Flow Cytometry: HLA B Antibody (2A11G7) [NBP2-61872] - Analysis of Hela cells using HLA-B mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/HLA-B-Antibody-2A11G7-Flow-Cytometry-NBP2-61872-img0002.jpg)
![Western Blot: HLA B Antibody (2A11G7) [NBP2-61872] - Analysis using HLA-B mAb against human HLA-B (AA: 241-362) recombinant protein. (Expected MW is 38.4 kDa)](http://images.novusbio.com/fullsize/HLA-B-Antibody-2A11G7-Western-Blot-NBP2-61872-img0005.jpg)
![Western Blot: HLA B Antibody (2A11G7) [NBP2-61872] - Analysis using HLA-B mouse mAb against Ramos (1) and A431 (2) cell lysate.](http://images.novusbio.com/fullsize/HLA-B-Antibody-2A11G7-Western-Blot-NBP2-61872-img0007.jpg)
![Immunohistochemistry-Paraffin: HLA B Antibody (2A11G7) [NBP2-61872] - Analysis of ovarian cancer tissues using HLA-B mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/HLA-B-Antibody-2A11G7-Immunohistochemistry-NBP2-61872-img0003.jpg)
![ELISA: HLA B Antibody (2A11G7) [NBP2-61872] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/HLA-B-Antibody-2A11G7-ELISA-NBP2-61872-img0001.jpg)
![Flow Cytometry: Fc gamma RIII (CD16) Antibody (MEM-154) [NB500-378] - Separation of FasL transfected L5178Y cells stained using anti-human CD178 (NOK-1) purified antibody (concentration in sample 9 ug/ml, GAM APC, red-filled) from FasL transfected L5178Y cells unstained by primary antibody (GAM APC, black-dashed) in flow cytometry analysis (surface staining).](http://images.novusbio.com/fullsize/Fc-gamma-RIII-CD16-Antibody-MEM-154-Flow-Cytometry-NB500-378-img0002.jpg "Flow Cytometry: Fc gamma RIII (CD16) Antibody (MEM-154) [NB500-378] - Separation of FasL transfected L5178Y cells stained using anti-human CD178 (NOK-1) purified antibody (concentration in sample 9 ug/ml, GAM APC, red-filled) from FasL transfected L5178Y cells unstained by primary antibody (GAM APC, black-dashed) in flow cytometry analysis (surface staining).")
![Flow Cytometry: Fc gamma RIII (CD16) Antibody (MEM-154) [NB500-378] - Flow cytometry surface staining pattern of human peripheral blood stained using Fc gamma RIII (CD16) Antibody (MEM-154) purified antibody (concentration in sample 2 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/Fc-gamma-RIII-CD16-Antibody-MEM-154-Flow-Cytometry-NB500-378-img0001.jpg)
![Flow Cytometry: Fc gamma RIII (CD16) Antibody (MEM-154) - BSA Free [NB500-378] - Staining of human peripheral blood cells with anti-human CD16 (MEM-154) purified, GAM/APC.](http://images.novusbio.com/fullsize/nb500-378_mouse-monoclonal-fc-gamma-riii-cd16-antibody-mem-154-17720241003218.jpg)